CPHI 2026: Finding the right CDMO partner in an age of consolidation
Executives from companies such as Leo Pharma and Daiichi Sankyo debated outsourcing selections and whether size is better in manufacturing.
Drug Manufacturers
Drug delivery’s next bottleneck isn’t innovation, it’s industrial capacity
How DFE Pharma supports confident continuous manufacturing decisions
Looking beyond short-term turmoil, Syngene is investing for the future
BMS Texas investment advances pharma’s modular manufacturing agenda
Industry partnership will determine the success of the transition to low-GWP pMDIs
Speciality versus diversity: the four-way CDMO race in outsourced HPAPI manufacturing
Turning AI skeptics into AI advocates through high-integrity data
